BDO has provided financial and tax vendor due diligence services to Prescient Healthcare Group (Prescient) on an investment by Bridgepoint Development Capital (BDC), replacing current investor Baird Capital as the majority shareholder.
Founded in 2007, Prescient is headquarted in London and has additional offices in the U.S., India and China. The business provides product strategy services to help its clients make better clinical and commercial decisions, resulting in enhanced outcomes for patients. Prescient partners with many of the world's leading multinational pharmaceutical companies, as well as a growing number of emerging biotech and specialty pharma organisations.
Prescient has formed a partnership with Bridgepoint to support the continued scaling of its talent platform, client value proposition and global infrastructure.
"The support provided by the BDO team was exceptional. They adopt such a collaborative way of working and were always willing to go over and beyond in their efforts to support all parties involved in the process. I very much look forward to working with them again in future."
Jamie Denison-Pender (CEO, Prescient Healthcare Group)